Price $15.65 |
Market Cap
602.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.12
|
P/S
1.67
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
-6.30%
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
2.2
|
Debt/Equity
20.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $17.50 | - | - | 5.89B | Strong Buy |
| Community Health Systems (CYH) | $9.27 | - | - | 1.15B | Strong Buy |
| Depomed Inc (DEPO) | $10.60 | - | - | 669.5M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.38 | - | - | 12.8M | Strong Buy |
| Genesis Healthcare Inc (GEN) | $1.44 | - | - | 265.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
